Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Fenbendazole
MSD Animal Health UK Limited
QP52AC13
Fenbendazole
Oral suspension
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Horses
Anthelmintic
Authorized
2000-09-05
Revised: December 2020 A/N: 01394/2020 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur Equine Guard 10% w/v Oral Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): % w/v Fenbendazole 10.000 Excipients Sodium Methyl Parahydroxybenzoate 0.200 Sodium Propyl Parahydroxybenzoate 0.0216 Benzyl Alcohol 0.4835 For full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral suspension. A white, aqueous suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses and other equines 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines. The product is also effective for the treatment and control of encysted mucosal 3rd and 4th stage small strongyle larvae and is also effective against encysted inhibited 3rd stage small strogyle larvae in the mucosa. The product is also effective in controlling other immature and mature roundworms including large redworm (_Strongylus edentatus _ and _ Strongylus _ _vulgaris_) and migrating large redworm, _Ascarids _ (_Parascaris _ _equorum_), _Oxyuris_ and _ Strongyloides_ species and benzimidazole susceptible adult and immature small strongyles (Cyathostomes). The product also has an ovicidal effect on nematode eggs. Revised: December 2020 A/N: 01394/2020 Page 2 of 5 4.3 CONTRA-INDICATIONS None known. 4.4 SPECIAL WARNING FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: • Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. • Under dosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Read the complete document